{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Liu LT"],"funding":["National Health Research Institutes, Taiwan","Ministry of Health and Welfare, Taiwan","National Health Research Institutes","Ministry of Health and Welfare"],"pagination":["624-636"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11895958"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["39(6)"],"pubmed_abstract":["In Taiwan, coronavirus disease 2019 (COVID-19) involving the delta variant occurred after that involving the alpha variant in 2021. In this study, we aimed to analyze the Delta variant. A total of 318 patients in Taiwan infected with delta variants were identified. The case fatality rate (CFR) of patients infected with delta variants was 0.94% in Taiwan compared with that of those infected with alpha variants (5.95%). The possible reasons for the low CFR might be hybrid immunity due to infection and rapid promotion of the COVID-19 vaccination program during the alpha variant outbreak. We identified three 21J delta variants. Two long gene deletions were detected in these severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) isolates: ORF7aΔ91 in KMUH-8 and SpikeΔ30 in KMUH-9. Protein"],"journal":["The Kaohsiung journal of medical sciences"],"pubmed_title":["The identification and phylogenetic analysis of SARS-CoV-2 delta variants in Taiwan."],"pmcid":["PMC11895958"],"funding_grant_id":["NHRI‐110A1‐MRCO‐03212101","MOHW109‐TDU‐B‐212‐114006","MOHW110-TDU-B-212-124006","MOHW109-TDU-B-212-114006","NHRI-110A1-MRCO-03212101","MOHW110‐TDU‐B‐212‐124006"],"pubmed_authors":["Tsai CY","Chu JJH","Hwang SJ","Chuang WL","Chong IW","Tsai JJ","Lin PC","Chen LJ","Hsu MC","Chen CH","Liu LT"],"additional_accession":[]},"is_claimable":false,"name":"The identification and phylogenetic analysis of SARS-CoV-2 delta variants in Taiwan.","description":"In Taiwan, coronavirus disease 2019 (COVID-19) involving the delta variant occurred after that involving the alpha variant in 2021. In this study, we aimed to analyze the Delta variant. A total of 318 patients in Taiwan infected with delta variants were identified. The case fatality rate (CFR) of patients infected with delta variants was 0.94% in Taiwan compared with that of those infected with alpha variants (5.95%). The possible reasons for the low CFR might be hybrid immunity due to infection and rapid promotion of the COVID-19 vaccination program during the alpha variant outbreak. We identified three 21J delta variants. Two long gene deletions were detected in these severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) isolates: ORF7aΔ91 in KMUH-8 and SpikeΔ30 in KMUH-9. Protein","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jun","modification":"2026-06-02T22:32:43.859Z","creation":"2026-05-28T03:05:39.198Z"},"accession":"S-EPMC11895958","cross_references":{"pubmed":["36951529"],"doi":["10.1002/kjm2.12665"]}}